NeurAxis Expands Payer Coverage with Four New Medical Policies
Neuraxis, Inc. (NRXS)
Company Research
Source: GlobeNewswire
CARMEL, Ind., April 22, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced four additional health insurers with medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), representing approximately 1.25 million covered lives. These medical policies expand incremental access to IB-Stim treatment for beneficiaries in West Virginia, New Hampshire, South Carolina, Virginia, and Florida. “Momentum in expanding insurance coverage for IB-Stim remains strong as we work to make this therapy more accessible and affordable to patients nationwide through written policy coverage on a national scale with all payers,” said Brian Carrico, CEO of NeurAxis. “Payers across the country are increasingly recognizing the efficacy of IB-Stim due to the Category I CPT code now being effectiv
Show less
Read more
Impact Snapshot
Event Time:
NRXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRXS alerts
High impacting Neuraxis, Inc. news events
Weekly update
A roundup of the hottest topics
NRXS
News
- NeurAxis, Inc. Announces Preferred Stock DividendGlobeNewswire
- NeurAxis (NRXS) had its price target raised by Craig Hallum from $8.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges [Yahoo! Finance]Yahoo! Finance
- NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 [Yahoo! Finance]Yahoo! Finance
NRXS
Sec Filings
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form DEF
- 4/28/26 - Form ARS
- NRXS's page on the SEC website